List of insiders holdings for Vera Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Longitude Capital Partners IV LLC Longitude Prime Partners LLC Longitude Prime Fund L.P. Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
2024-11-04 19:49:25 | 5,184,062 0 |
5,184,062 | Form 13D |
2 | EMSTER KURT VON Director |
2021-05-18 20:10:03 | 17,828 2,960,231 |
2,978,059 | Form 4 |
3 | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
2024-03-26 19:57:53 | 2,813,837 0 |
2,813,837 | Form 13D |
4 | Sofinnova Venture Partners X L.P. Sofinnova Management X L.P. HEALY JAMES Katabi Maha Sofinnova Management X-A L.L.C. 10% Owner |
2024-03-26 19:57:53 | 2,813,837 0 |
2,813,837 | Form 13D |
5 | COMMODORE CAPITAL LP 10% Owner |
2024-11-14 16:10:28 | 2,475,000 0 |
2,475,000 | Form 13G |
6 | Ares Trading S.A. Merck KGaA MERCK SERONO S.A. 10% Owner |
2024-02-14 15:21:33 | 1,913,501 0 |
1,913,501 | Form 13G |
7 | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
2023-08-02 17:01:28 | 1,872,764 0 |
1,872,764 | Form 13D |
8 | Fordyce Marshall PRESIDENT AND CEO |
2025-02-27 16:05:29 | 204,665 222,030 |
426,695 | Form 4 |
9 | Carter Jason S Chief Legal Officer |
2024-11-20 16:07:22 | 161,000 0 |
161,000 | Form 4 |
10 | Grant Sean CHIEF FINANCIAL OFFICER |
2025-02-20 16:08:57 | 147,037 5,000 |
152,037 | Form 4 |
11 | SEIDENBERG BETH C Director |
2024-10-30 16:06:24 | 131,553 4,012 |
135,565 | Form 4 |
12 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR |
2025-02-20 16:13:15 | 83,446 0 |
83,446 | Form 4 |
13 | Brenner Robert Chief Medical Officer |
2025-02-20 16:10:21 | 81,274 0 |
81,274 | Form 4 |
14 | JOHNSON DAVID LEE Chief Operating Officer |
2025-02-20 16:05:47 | 80,700 0 |
80,700 | Form 4 |
15 | Turner William D. Chief Development Officer |
2025-02-20 16:11:50 | 67,500 0 |
67,500 | Form 4 |
16 | Curley Joanne Chief Development Officer |
2023-08-23 17:57:54 | 26,962 0 |
26,962 | Form 4 |
17 | Oliger Christy J. Director |
2024-06-11 16:16:18 | 25,000 0 |
25,000 | Form 4 |
18 | Morrison Scott W Director |
2024-05-17 16:15:53 | 14,000 0 |
14,000 | Form 4 |
19 | MORRISSEY MICHAEL Director |
2024-05-17 16:14:35 | 14,000 0 |
14,000 | Form 4 |
20 | Katabi Maha Director |
2024-05-17 16:13:27 | 14,000 0 |
14,000 | Form 4 |
21 | Hall Kimball Director |
2024-05-17 16:12:06 | 14,000 0 |
14,000 | Form 4 |
22 | ENRIGHT PATRICK G Director |
2024-05-17 16:10:26 | 14,000 0 |
14,000 | Form 4 |
23 | Cheng Andrew Director |
2024-05-17 16:08:44 | 14,000 0 |
14,000 | Form 4 |
24 | Lin Celia Chief Medical Officer |
2023-08-23 17:59:56 | 11,010 0 |
11,010 | Form 4 |
25 | Wolter Jonathan Chief Financial Officer |
2021-05-13 19:05:22 | 0 0 |
0 | Form 3 |